Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Pneumococcal Immunization: later-stage trial registry

1 of 4 indexed Pneumococcal Immunization trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Pneumococcal Immunization: 4 US clinical trials tracked, 1 recruiting.

Pneumococcal Immunization is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Sanofi Pasteur, a Sanofi Company, running 2 of these trials.

Enrollment posture brief

Registry condition pneumococcal-immunization

OPEN 1 | RECR 25% | LATE 3 | EARLY 1 | RANK #4115 | SPON 2

Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Pneumococcal Immunizatio (th…25%
Open-enrollment share among volume-matched conditions near Pneumococcal Immunization

Pneumococcal Immunization lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pneumococcal Immunization on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pneumococcal Immunization is recruiting below its size-band peers.

    1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 33

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 3

Top Sponsors

Named interventions

Most-linked intervention names on Pneumococcal Immunization records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

RotaTeq Biological
3 trials
M-M-R II vaccine Biological
3 trials
Prevnar 20 vaccine Biological
3 trials
PCV21 vaccine Biological
3 trials
Rotarix Biological
2 trials
Pneumococcal Conjugate Vaccine Biological
1 trials
Prevnar 13® Biological
1 trials
Vaxelis vaccine Biological
1 trials

US sites by state

Facility locations filed on Pneumococcal Immunization trials. A trial with sites in several states counts in each.

California 3 trials
Louisiana 2 trials
Florida 2 trials
Arizona 2 trials
Arkansas 2 trials
Texas 1 trials
South Carolina 1 trials
Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pneumococcal Immunization page

4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pneumococcal Immunization condition card totals 4 registered trials; most-linked intervention RotaTeq; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.